Dukem Bio to Build Korea's First Radioactive Pharma CDMO in Jeongeup

Dukem Bio announced plans to establish South Korea's first radioactive‑pharmaceutical contract development and manufacturing organization (CDMO) plant in Jeongeup, North Jeolla Province. The project will integrate isotope production, drug manufacturing, and export capabilities in a single supply chain, positioning Jeongeup as a regional hub for radioactive medicines in East Asia. On April 4, Dukem Bio signed an investment agreement with the Jeollabuk‑do provincial government and Jeongeup city for a 34.3 billion KRW RPT‑specialized CDMO facility and R&D center. The plant and research complex will be located in the Shinjeong‑dong advanced industrial zone, with construction slated for completion by 2032.